Expected earnings - Boundless Bio Inc.
Source: US Earnings Reports
Boundless Bio Inc. (BOLD) is expected to report $-0.44 for Q4 2025
Audentes Therapeutics Inc.
NASDAQ: BOLD
BOLD Trading
0.42% G/L:
$1.1599 Last:
35,727 Volume:
$1.15 Open:
BOLD Latest News
March 09, 2026 07:00:00 am
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 05, 2026 07:00:00 am
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
BOLD Stock Data
$25,819,564
17,662,247
6.34%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
